Gurpreet K Rihal, MD
Gastroenterology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Looking this up.
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Rihal’s office at (408) 972-3000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
California Medical Board record
Licence A53753 · Current
Licensed to practise in California · since 1994 · expires 2028-12-31 · Meerut University, L. L. R. M. Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Procedures Medicare counted
| Upper gastrointestinal (GI) endoscopy for acid reflux | 1-10 | None |
Drugs they prescribed that Part D paid
$161,410
Pharmacies billed $161,410 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 590) in 2024. At or below the middle of the specialty; the typical gastroenterology clinician is at 0%.
467 generic and 123 brand-name prescriptions · $161,410 in drug cost · 17 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Mesalamine | 78 | $40,165 | $515 |
| Budesonide Er | 42 | $19,571 | $466 |
| Ursodiol | 22 | $4,992 | $227 |
| Colesevelam | 38 | $4,457 | $117 |
| Sucralfate | 22 | $2,578 | $117 |
See all 13 drugs
| Mesalamine | 78 | $40,165 | $515 |
| Budesonide Er | 42 | $19,571 | $466 |
| Ursodiol | 22 | $4,992 | $227 |
| Colesevelam | 38 | $4,457 | $117 |
| Sucralfate | 22 | $2,578 | $117 |
| Gavilyte-C | 113 | $2,535 | $22 |
| Lactulose | 15 | $1,007 | $67 |
| Azathioprine | 16 | $615 | $38 |
| Entecavir | 13 | $516 | $40 |
| Omeprazole | 48 | $472 | $10 |
| Cholestyramine | 11 | $442 | $40 |
| Famotidine | 24 | $355 | $15 |
| Pantoprazole | 22 | $286 | $13 |
Year by year
| 2024 | 590 | 219 | 0% (0) | 21% | $161,410 |
| 2023 | 601 | 230 | 0% (0) | 26% | $213,687 |
| 2022 | 645 | 237 | 0% (0) | 33% | $175,921 |
| 2021 | 753 | 254 | 0% (0) | 33% | $260,123 |
| 2020 | 672 | 216 | 0% (0) | 38% | $191,349 |
| 2019 | 804 | 334 | 0% (0) | 31% | $255,826 |
| 2018 | 672 | 256 | 0% (0) | 48% | $261,176 |
| 2017 | 699 | 244 | 0% (0) | 41% | $734,350 |
| 2016 | 888 | 384 | 0% (0) | None | $2,547,912 |
| 2015 | 878 | 322 | 0% (0) | 42% | $2,321,849 |
| 2014 | 667 | 289 | None | None | $426,352 |
| 2013 | 533 | 251 | 0% (0) | None | $161,070 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 16 drugs
| Creon | 18 | $65,113 | $3,617 |
| Zenpep | 11 | $29,798 | $2,709 |
| Lialda | 62 | $29,724 | $479 |
| Budesonide Er | 13 | $13,273 | $1,021 |
| Mesalamine | 20 | $8,401 | $420 |
| Colesevelam | 45 | $5,791 | $129 |
| Ursodiol | 22 | $5,022 | $228 |
| Sucralfate | 18 | $2,853 | $159 |
| Gavilyte-C | 132 | $2,758 | $21 |
| Entecavir | 17 | $1,044 | $61 |
| Azathioprine | 20 | $874 | $44 |
| Diphenoxylate-Atropine | 25 | $734 | $29 |
| Peg-3350 and Electrolytes | 20 | $510 | $25 |
| Omeprazole | 41 | $419 | $10 |
| Famotidine | 18 | $310 | $17 |
| Pantoprazole | 13 | $196 | $15 |
2022: 16 drugs
| Lialda | 80 | $34,899 | $436 |
| Budesonide Er | 19 | $24,375 | $1,283 |
| Mesalamine | 13 | $7,144 | $550 |
| Ursodiol | 22 | $4,751 | $216 |
| Sucralfate | 28 | $2,031 | $73 |
| Gavilyte-C | 110 | $1,986 | $18 |
| Colesevelam | 36 | $1,768 | $49 |
| Azathioprine | 24 | $1,249 | $52 |
| Entecavir | 17 | $1,061 | $62 |
| Diphenoxylate-Atropine | 24 | $751 | $31 |
| Peg-3350 and Electrolytes | 34 | $736 | $22 |
| Omeprazole | 52 | $498 | $10 |
| Famotidine | 36 | $487 | $14 |
| Pantoprazole | 17 | $241 | $14 |
| Ondansetron Odt | 12 | $224 | $19 |
| Metronidazole | 13 | $122 | $9 |
2021: 17 drugs
| Xifaxan | 39 | $122,937 | $3,152 |
| Lialda | 96 | $41,649 | $434 |
| Budesonide Er | 19 | $16,576 | $872 |
| Mesalamine | 28 | $12,378 | $442 |
| Famotidine | 66 | $9,223 | $140 |
| Sucralfate | 39 | $6,106 | $157 |
| Ursodiol | 25 | $4,103 | $164 |
| Azathioprine | 23 | $2,077 | $90 |
| Colesevelam | 36 | $1,827 | $51 |
| Peg-3350 and Electrolytes | 87 | $1,778 | $20 |
| Entecavir | 15 | $1,074 | $72 |
| Omeprazole | 42 | $791 | $19 |
| Gavilyte-C | 49 | $739 | $15 |
| Diphenoxylate-Atropine | 23 | $696 | $30 |
| Pantoprazole | 30 | $517 | $17 |
| Metronidazole | 11 | $113 | $10 |
| Ciprofloxacin | 11 | $94 | $9 |
2020: 17 drugs
| Xifaxan | 20 | $47,525 | $2,376 |
| Budesonide Er | 21 | $25,897 | $1,233 |
| Lialda | 50 | $20,530 | $411 |
| Mesalamine | 53 | $18,164 | $343 |
| Amitiza | 12 | $10,357 | $863 |
| Famotidine | 49 | $5,708 | $116 |
| Sucralfate | 39 | $4,817 | $124 |
| Ursodiol | 25 | $3,690 | $148 |
| Budesonide Ec | 22 | $2,626 | $119 |
| Entecavir | 15 | $2,298 | $153 |
| Azathioprine | 15 | $1,649 | $110 |
| Gavilyte-C | 67 | $1,385 | $21 |
| Colesevelam | 14 | $1,235 | $88 |
| Omeprazole | 55 | $1,077 | $20 |
| Diphenoxylate-Atropine | 20 | $904 | $45 |
| Peg-3350 and Electrolytes | 33 | $712 | $22 |
| Pantoprazole | 32 | $496 | $15 |
2019: 21 drugs
| Lialda | 68 | $55,531 | $817 |
| Xifaxan | 22 | $47,301 | $2,150 |
| Budesonide Er | 34 | $41,893 | $1,232 |
| Mesalamine | 25 | $11,344 | $454 |
| Adefovir Dipivoxil | 12 | $10,742 | $895 |
| Gavilyte-C | 176 | $6,322 | $36 |
| Ursodiol | 25 | $3,552 | $142 |
| Entecavir | 17 | $3,454 | $203 |
| Budesonide Ec | 22 | $3,201 | $146 |
| Mercaptopurine | 11 | $2,782 | $253 |
| Sucralfate | 32 | $1,866 | $58 |
| Omeprazole | 88 | $1,637 | $19 |
| Azathioprine | 13 | $1,446 | $111 |
| Sulfasalazine | 12 | $1,203 | $100 |
| Lamivudine Hbv | 11 | $1,156 | $105 |
| Diphenoxylate-Atropine | 18 | $974 | $54 |
| Gavilyte-G | 25 | $605 | $24 |
| Colesevelam | 11 | $575 | $52 |
| Pantoprazole | 24 | $437 | $18 |
| Famotidine | 21 | $350 | $17 |
| Metronidazole | 11 | $100 | $9 |
2018: 16 drugs
| Lialda | 61 | $76,598 | $1,256 |
| Xifaxan | 21 | $41,394 | $1,971 |
| Uceris | 14 | $25,041 | $1,789 |
| Canasa | 15 | $20,007 | $1,334 |
| Entecavir | 27 | $4,965 | $184 |
| Budesonide Ec | 20 | $4,511 | $226 |
| Ursodiol | 23 | $3,613 | $157 |
| Sucralfate | 48 | $2,967 | $62 |
| Gavilyte-C | 60 | $2,172 | $36 |
| Peg 3350-Electrolyte | 55 | $1,991 | $36 |
| Omeprazole | 78 | $1,791 | $23 |
| Sulfasalazine | 21 | $1,687 | $80 |
| Azathioprine | 17 | $1,391 | $82 |
| Diphenoxylate-Atropine | 13 | $956 | $74 |
| Famotidine | 20 | $460 | $23 |
| Pantoprazole | 17 | $407 | $24 |
2017: 17 drugs
| Harvoni | 11 | $166,465 | $15,133 |
| Lialda | 61 | $83,743 | $1,373 |
| Xifaxan | 33 | $58,703 | $1,779 |
| Humira | 13 | $48,031 | $3,695 |
| Entecavir | 27 | $25,167 | $932 |
| Pentasa | 20 | $22,109 | $1,105 |
| Budesonide Ec | 23 | $19,044 | $828 |
| Balsalazide Disodium | 17 | $5,122 | $301 |
| Ursodiol | 16 | $2,969 | $186 |
| Sulfasalazine | 22 | $2,705 | $123 |
| Omeprazole | 88 | $2,481 | $28 |
| Sucralfate | 33 | $2,423 | $73 |
| Azathioprine | 18 | $2,101 | $117 |
| Gavilyte-C | 115 | $1,979 | $17 |
| Diphenoxylate-Atropine | 14 | $1,075 | $77 |
| Famotidine | 14 | $382 | $27 |
| Pantoprazole | 12 | $329 | $27 |
2016: 23 drugs
| Harvoni | 51 | $1,069,158 | $20,964 |
| Sovaldi | 20 | $538,801 | $26,940 |
| Xifaxan | 38 | $67,843 | $1,785 |
| Lialda | 51 | $56,665 | $1,111 |
| Entecavir | 26 | $47,475 | $1,826 |
| Humira | 12 | $40,806 | $3,401 |
| Pentasa | 14 | $15,330 | $1,095 |
| Balsalazide Disodium | 21 | $15,262 | $727 |
| Budesonide Ec | 15 | $13,665 | $911 |
| Canasa | 11 | $11,495 | $1,045 |
| Carafate | 22 | $10,087 | $458 |
| Ursodiol | 13 | $8,726 | $671 |
| Ribasphere | 34 | $4,825 | $142 |
| Lamivudine Hbv | 12 | $4,694 | $391 |
| Gavilyte-C | 210 | $3,592 | $17 |
| Sulfasalazine | 27 | $3,576 | $132 |
| Mercaptopurine | 11 | $3,511 | $319 |
| Omeprazole | 70 | $2,705 | $39 |
| Diphenoxylate-Atropine | 15 | $880 | $59 |
| Famotidine | 21 | $806 | $38 |
| Pantoprazole | 12 | $419 | $35 |
| Peg 3350-Electrolyte | 13 | $221 | $17 |
| Ondansetron | 12 | $153 | $13 |
2015: 19 drugs
| Harvoni | 93 | $1,304,327 | $14,025 |
| Sovaldi | 29 | $527,394 | $18,186 |
| Lialda | 41 | $56,343 | $1,374 |
| Xifaxan | 19 | $39,996 | $2,105 |
| Entecavir | 20 | $39,633 | $1,982 |
| Balsalazide Disodium | 39 | $19,491 | $500 |
| Budesonide Ec | 11 | $12,835 | $1,167 |
| Welchol | 14 | $11,752 | $839 |
| Carafate | 27 | $11,447 | $424 |
| Ursodiol | 25 | $7,610 | $304 |
| Sulfasalazine | 35 | $4,062 | $116 |
| Mercaptopurine | 11 | $3,322 | $302 |
| Omeprazole | 80 | $3,287 | $41 |
| Gavilyte-C | 182 | $3,106 | $17 |
| Ribasphere | 21 | $2,692 | $128 |
| Diphenoxylate-Atropine | 16 | $783 | $49 |
| Famotidine | 17 | $560 | $33 |
| Pantoprazole | 13 | $500 | $38 |
| Spironolactone | 11 | $139 | $13 |
2014: 14 drugs
| Lialda | 36 | $52,717 | $1,464 |
| Xifaxan | 16 | $29,918 | $1,870 |
| Balsalazide Disodium | 41 | $20,365 | $497 |
| Budesonide Ec | 11 | $16,075 | $1,461 |
| Carafate | 37 | $13,184 | $356 |
| Dipentum | 11 | $9,620 | $875 |
| Omeprazole | 66 | $2,652 | $40 |
| Sulfazine | 26 | $2,481 | $95 |
| Gavilyte-C | 122 | $2,085 | $17 |
| Pantoprazole | 35 | $933 | $27 |
| Diphenoxylate-Atropine | 21 | $845 | $40 |
| Peg 3350-Electrolyte | 42 | $692 | $16 |
| Famotidine | 17 | $476 | $28 |
| Ciprofloxacin | 19 | $212 | $11 |
2013: 9 drugs
| Lialda | 34 | $37,352 | $1,099 |
| Xifaxan | 15 | $20,730 | $1,382 |
| Asacol | 15 | $18,349 | $1,223 |
| Balsalazide Disodium | 31 | $6,606 | $213 |
| Carafate | 13 | $4,040 | $311 |
| Omeprazole | 75 | $3,126 | $42 |
| Gavilyte-C | 151 | $2,567 | $17 |
| Sulfazine | 16 | $1,668 | $104 |
| Pantoprazole | 26 | $790 | $30 |
Money from drug and device companies
$105 in 2025
A payment is not proof that care is biased.
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $105 | 1 payment
|
See the published payment
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-12-15 | Xifaxan | $105 |
Professional record
- NPI
- 1093891509
- Licence
- CA A53753California A53753: Current · expires 2028-12-31
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A537530
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X)
- Mailing address
- 1800 Harrison St Fl 7, Oakland, CA, 94612
- NPI first listed
- 2006-10-27
- NPI last updated
- 2021-12-13
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.